Position in ALT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$502,785
+$217,849 QoQ
Shares Held
165,390
+78.8% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ALT ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in ALT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $502,785 | 165,390 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $284,936 | 92,512 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $180,063 | 49,879 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $156,428 | 41,493 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $132,473 | 34,231 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $157,390 | 31,478 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $202,932 | 28,146 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $147,286 | 23,988 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $150,742 | 22,668 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $155,122 | 15,238 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $150,941 | 13,417 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $26,122 | 10,047 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $90,533 | 25,647 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $83,556 | 19,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $590,555 | 35,900 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,719,020 | 134,614 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $416,520 | 35,600 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $237,832 | 39,053 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $350,086 | 38,219 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $365,527 | 32,319 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $315,052 | 31,985 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $679,653 | 48,100 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $462,480 | 41,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $216,480 | 16,400 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||